US Stock MarketDetailed Quotes

COCP Cocrystal Pharma

Watchlist
  • 1.8600
  • -0.0300-1.59%
Close Aug 28 16:00 ET
18.92MMarket Cap-1062P/E (TTM)

Cocrystal Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
25.56%5.45M
-18.65%4.16M
16.66%21.16M
25.86%5.67M
6.13%6.04M
16.14%4.34M
21.55%5.11M
27.54%18.14M
21.61%4.5M
44.04%5.69M
Selling and administrative expenses
-25.88%1.14M
0.33%1.21M
4.26%5.99M
15.14%1.4M
1.48%1.85M
11.85%1.54M
-9.68%1.2M
5.86%5.75M
25.39%1.22M
-1.41%1.82M
-General and administrative expense
-25.88%1.14M
0.33%1.21M
4.26%5.99M
15.14%1.4M
1.48%1.85M
11.85%1.54M
-9.68%1.2M
5.86%5.75M
25.39%1.22M
-1.41%1.82M
Research and development costs
53.80%4.31M
-24.49%2.95M
22.41%15.17M
29.81%4.27M
8.32%4.19M
18.64%2.8M
36.04%3.91M
40.91%12.39M
20.27%3.29M
83.94%3.87M
Operating profit
-25.56%-5.45M
18.65%-4.16M
-16.66%-21.16M
-25.86%-5.67M
-6.13%-6.04M
-16.14%-4.34M
-21.55%-5.11M
-27.54%-18.14M
-21.61%-4.5M
-44.04%-5.69M
Net non-operating interest income expense
7.86%151K
220K
32,100.00%640K
180K
32,100.00%320K
140K
0
50.00%-2K
0
0.00%-1K
Total other finance cost
-7.86%-151K
---220K
-32,100.00%-640K
---180K
-32,100.00%-320K
---140K
----
--2K
--0
--1K
Other net income (expense)
-239.39%-46K
76.92%-18K
112.25%2.54M
102,100.00%1.02M
31,260.00%1.56M
100.16%33K
-3,800.00%-78K
-51,845.00%-20.7M
-94.12%1K
-138.46%-5K
Gain on sale of security
-239.39%-46K
76.92%-18K
-983.33%-65K
2,100.00%22K
-740.00%-42K
--33K
-3,800.00%-78K
-115.00%-6K
-94.12%1K
-138.46%-5K
Special income (charges)
----
----
112.57%2.6M
--1M
--1.6M
----
----
---20.69M
--0
--0
-Less:Impairment of capital assets
----
----
--0
--0
--0
----
----
--19.09M
--0
--0
-Less:Other special charges
----
----
-262.50%-2.6M
---1M
---1.6M
----
----
--1.6M
--0
----
Income before tax
-28.25%-5.34M
23.76%-3.96M
53.69%-17.98M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-173.79%-38.84M
-22.14%-4.5M
-44.63%-5.7M
Income tax
Net income
-28.25%-5.34M
23.76%-3.96M
53.69%-17.98M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-173.79%-38.84M
-22.14%-4.5M
-44.63%-5.7M
Net income continuous Operations
-28.25%-5.34M
23.76%-3.96M
53.69%-17.98M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-173.79%-38.84M
-22.14%-4.5M
-44.63%-5.7M
Minority interest income
Net income attributable to the parent company
-28.25%-5.34M
23.76%-3.96M
53.69%-17.98M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-173.79%-38.84M
-22.14%-4.5M
-44.63%-5.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.25%-5.34M
23.76%-3.96M
53.69%-17.98M
0.82%-4.46M
26.93%-4.17M
82.95%-4.17M
-23.31%-5.19M
-173.79%-38.84M
-22.14%-4.5M
-44.63%-5.7M
Basic earnings per share
-29.27%-0.53
39.06%-0.39
60.80%-1.87
18.52%-0.44
41.43%-0.41
86.33%-0.41
-23.08%-0.64
-2,881.25%-4.77
-142.19%-0.54
-45.83%-0.7
Diluted earnings per share
-29.27%-0.53
39.06%-0.39
60.80%-1.87
18.52%-0.44
41.43%-0.41
86.33%-0.41
-23.08%-0.64
-2,881.25%-4.77
-142.19%-0.54
-45.83%-0.7
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 25.56%5.45M-18.65%4.16M16.66%21.16M25.86%5.67M6.13%6.04M16.14%4.34M21.55%5.11M27.54%18.14M21.61%4.5M44.04%5.69M
Selling and administrative expenses -25.88%1.14M0.33%1.21M4.26%5.99M15.14%1.4M1.48%1.85M11.85%1.54M-9.68%1.2M5.86%5.75M25.39%1.22M-1.41%1.82M
-General and administrative expense -25.88%1.14M0.33%1.21M4.26%5.99M15.14%1.4M1.48%1.85M11.85%1.54M-9.68%1.2M5.86%5.75M25.39%1.22M-1.41%1.82M
Research and development costs 53.80%4.31M-24.49%2.95M22.41%15.17M29.81%4.27M8.32%4.19M18.64%2.8M36.04%3.91M40.91%12.39M20.27%3.29M83.94%3.87M
Operating profit -25.56%-5.45M18.65%-4.16M-16.66%-21.16M-25.86%-5.67M-6.13%-6.04M-16.14%-4.34M-21.55%-5.11M-27.54%-18.14M-21.61%-4.5M-44.04%-5.69M
Net non-operating interest income expense 7.86%151K220K32,100.00%640K180K32,100.00%320K140K050.00%-2K00.00%-1K
Total other finance cost -7.86%-151K---220K-32,100.00%-640K---180K-32,100.00%-320K---140K------2K--0--1K
Other net income (expense) -239.39%-46K76.92%-18K112.25%2.54M102,100.00%1.02M31,260.00%1.56M100.16%33K-3,800.00%-78K-51,845.00%-20.7M-94.12%1K-138.46%-5K
Gain on sale of security -239.39%-46K76.92%-18K-983.33%-65K2,100.00%22K-740.00%-42K--33K-3,800.00%-78K-115.00%-6K-94.12%1K-138.46%-5K
Special income (charges) --------112.57%2.6M--1M--1.6M-----------20.69M--0--0
-Less:Impairment of capital assets ----------0--0--0----------19.09M--0--0
-Less:Other special charges ---------262.50%-2.6M---1M---1.6M----------1.6M--0----
Income before tax -28.25%-5.34M23.76%-3.96M53.69%-17.98M0.82%-4.46M26.93%-4.17M82.95%-4.17M-23.31%-5.19M-173.79%-38.84M-22.14%-4.5M-44.63%-5.7M
Income tax
Net income -28.25%-5.34M23.76%-3.96M53.69%-17.98M0.82%-4.46M26.93%-4.17M82.95%-4.17M-23.31%-5.19M-173.79%-38.84M-22.14%-4.5M-44.63%-5.7M
Net income continuous Operations -28.25%-5.34M23.76%-3.96M53.69%-17.98M0.82%-4.46M26.93%-4.17M82.95%-4.17M-23.31%-5.19M-173.79%-38.84M-22.14%-4.5M-44.63%-5.7M
Minority interest income
Net income attributable to the parent company -28.25%-5.34M23.76%-3.96M53.69%-17.98M0.82%-4.46M26.93%-4.17M82.95%-4.17M-23.31%-5.19M-173.79%-38.84M-22.14%-4.5M-44.63%-5.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.25%-5.34M23.76%-3.96M53.69%-17.98M0.82%-4.46M26.93%-4.17M82.95%-4.17M-23.31%-5.19M-173.79%-38.84M-22.14%-4.5M-44.63%-5.7M
Basic earnings per share -29.27%-0.5339.06%-0.3960.80%-1.8718.52%-0.4441.43%-0.4186.33%-0.41-23.08%-0.64-2,881.25%-4.77-142.19%-0.54-45.83%-0.7
Diluted earnings per share -29.27%-0.5339.06%-0.3960.80%-1.8718.52%-0.4441.43%-0.4186.33%-0.41-23.08%-0.64-2,881.25%-4.77-142.19%-0.54-45.83%-0.7
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg